SOLV Performance: 1% Return (12 Months)
SOLV returned 0.9% over 12 months, underperforming the S&P 500 (31.0%). Volatility: 31.5%.
RS IBD
-28.15
Top 68% in Peers
Volatility
31.5%
Top 22% in Peers
Total Return 12m
0.95%
Top 57% in Peers
RS Rating
17.16
Top 68% in Peers
P/E
| P/E Trailing | 7.04 |
| P/E Forward | 10.0 |
High / Low 52w
| 52 Week High | 86.14 USD |
| 52 Week Low | 62.49 USD |
Sentiment
| VRO Trend Strength ±100 | 36.47 |
| Buy Signal ±3 | -0.38 |
Drawdowns 3y
| Max Drawdown | 39.97% |
| Mean Drawdown | 15.39% |
Compare vs 84 peers in Health Care Equipment
12m Total Return: SOLV (1%) vs PEER ETF
5y Drawdown (Underwater) Chart
Top Performer in Health Care Equipment (5/84)
Short Term Performance
| SYMBOL | 1W | 1M | 3M |
|---|---|---|---|
| CATX | 2.05% | -16.45% | 85.48% |
| LMAT | 5.00% | 5.21% | 37.05% |
| MASS | 4.23% | 14.06% | 30.29% |
| VMD | -2.56% | 0.11% | 30.27% |
| BWAY | 10.65% | 9.52% | 15.09% |
| SOLV | 4.02% | -2.68% | -23.22% |
Long Term Performance
| SYMBOL | 6M | 12M | 5Y |
|---|---|---|---|
| BWAY | 84.62% | 230.25% | 204.93% |
| AXGN | 99.87% | 102.28% | 61.90% |
| TALK | 71.19% | 90.07% | -47.94% |
| BFLY | 80.26% | 79.48% | -74.89% |
| TCMD | 64.77% | 74.85% | -56.47% |
| SOLV | -6.71% | 0.95% | -17.76% |
Overall Best Picks of Peer Group (GARP Metrics)
| SYMBOL | MCAP | 1M | 12M | 5Y | P/E | P/E fwd | PEG | EPS stab | EPS cagr |
|---|---|---|---|---|---|---|---|---|---|
| BWAY NASDAQ Brainsway |
572M | 9.52% | 230% | 205% | 75.3 | 64.5 | - | 83.9% | 20.2% |
| LMAT NASDAQ LeMaitre Vascular |
2.57B | 5.21% | 42.2% | 141% | 44.7 | 39.1 | 3.25 | 45.5% | -34.6% |
| IRMD NASDAQ Iradimed |
1.24B | -5.60% | 89.2% | 324% | 55.6 | 45.9 | 4.46 | 90.1% | 27.1% |
| BVS NASDAQ Bioventus |
604M | 2.26% | 19.7% | -34.4% | 27.2 | 11.9 | 1.19 | 47.0% | 61.3% |
| GMED NYSE Globus Medical |
11.9B | 4.35% | 27.4% | 33.8% | 22.4 | 19.7 | 1.49 | 91.5% | 34.6% |
| SNN NYSE Smith & Nephew SNATS |
13.5B | 2.77% | 36.8% | -0.84% | 22.2 | 12.5 | 0.66 | 0.90% | -69.0% |
| TCMD NASDAQ Tactile Systems Technology |
547M | -16.7% | 74.9% | -56.5% | 29.3 | 19.1 | 17.8 | 49.8% | 172% |
| IDXX NASDAQ IDEXX Laboratories |
46.6B | -5.99% | 47.5% | 11.2% | 44.6 | 39.5 | 3.96 | 78.4% | 8.48% |
| AVR NASDAQ Anteris Technologies Global |
517M | -11.0% | 92.9% | -5.33% | - | - | - | 32.6% | 331% |
| PEN NYSE Penumbra |
13.0B | -2.07% | 22.8% | 24.0% | 72.9 | 64.1 | 0.75 | 60.5% | -3.72% |
Compare SOLV vs S&P 500
Total Return vs S&P 500
| PERIOD | SOLV | S&P 500 |
|---|---|---|
| 1 Week | 4.02% | 3.12% |
| 1 Month | -2.68% | 0.61% |
| 3 Months | -23.22% | -1.99% |
| 6 Months | -6.71% | 4.64% |
| 12 Months | 0.95% | 31.01% |
| 5 Years | -17.76% | 76.73% |
FAQ
Does SOLV outperform the market?
No, SOLV underperforms the market. Over the past 12 months, SOLV returned 0.95% compared to 31.01% for the S&P 500.
What is the SOLV return over the last 12 months?
SOLV has returned 0.95% over the past 12 months, including dividends. Over 3 months the return was -23.22%, and over 5 years -17.76%.
How risky is SOLV?
SOLV has relatively low risk with a maximum drawdown of 39.97% over the past 3 years. The average drawdown is 15.39%.
SOLV vs Sectors (12m)
Relative Performance vs S&P Sectors
Sorted by outperformance, Positive = SOLV beats sector.
| SECTOR | ETF | DIFFERENCE 12M |
|---|---|---|
| Consumer Staples | XLP | -5.7% |
| Health Care | XLV | -10.2% |
| Financials | XLF | -11.3% |
| Real Estate | XLRE | -14.5% |
| Consumer Discretionary | XLY | -20.2% |
| Communication Services | XLC | -26.5% |
| Communication Services | XLC | -26.5% |
| Materials | XLB | -34.6% |
| Industrials | XLI | -39.8% |
| Technology | XLK | -46.6% |
| Energy | XLE | -51.7% |
SOLV vs Asset Classes (12m)
Relative Performance vs Major Asset Classes
| ASSET CLASS | ETF | DIFFERENCE 12M |
|---|---|---|
| S&P 500 | SPY | -30.1% |
| Emerging Market | EEM | -52.3% |
| Gold | GLD | -48.6% |
| Long-Term Bonds | TLT | -3.7% |
| Risk-Free Cash | SHY | -2.6% |